These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31407832)

  • 21. Enzymatic Targets in Trypanosoma brucei.
    Scotti L; Mendonça FJ; da Silva MS; Scotti MT
    Curr Protein Pept Sci; 2016; 17(3):243-59. PubMed ID: 26983886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Charge is the major discriminating factor for glutathione reductase versus trypanothione reductase inhibitors.
    Faerman CH; Savvides SN; Strickland C; Breidenbach MA; Ponasik JA; Ganem B; Ripoll D; Krauth-Siegel RL; Karplus PA
    Bioorg Med Chem; 1996 Aug; 4(8):1247-53. PubMed ID: 8879546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular studies on trypanothione reductase: an antiparasitic target enzyme.
    Walsh C; Bradley M; Nadeau K
    Curr Top Cell Regul; 1992; 33():409-17. PubMed ID: 1354149
    [No Abstract]   [Full Text] [Related]  

  • 24. 2- and 3-substituted 1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: synthesis and correlation between redox cycling activities and in vitro cytotoxicity.
    Salmon-Chemin L; Buisine E; Yardley V; Kohler S; Debreu MA; Landry V; Sergheraert C; Croft SL; Krauth-Siegel RL; Davioud-Charvet E
    J Med Chem; 2001 Feb; 44(4):548-65. PubMed ID: 11170645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New spermine and spermidine derivatives as potent inhibitors of Trypanosoma cruzi trypanothione reductase.
    Bonnet B; Soullez D; Davioud-Charvet E; Landry V; Horvath D; Sergheraert C
    Bioorg Med Chem; 1997 Jul; 5(7):1249-56. PubMed ID: 9377084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanomolar Inhibitors of Trypanosoma brucei RNA Triphosphatase.
    Smith P; Ho CK; Takagi Y; Djaballah H; Shuman S
    mBio; 2016 Feb; 7(1):e00058-16. PubMed ID: 26908574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developing imidazole analogues as potential inhibitor for Leishmania donovani trypanothione reductase: virtual screening, molecular docking, dynamics and ADMET approach.
    Pandey RK; Sharma D; Bhatt TK; Sundar S; Prajapati VK
    J Biomol Struct Dyn; 2015; 33(12):2541-53. PubMed ID: 26305585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trypanothione reductase: a target protein for a combined in vitro and in silico screening approach.
    Beig M; Oellien F; Garoff L; Noack S; Krauth-Siegel RL; Selzer PM
    PLoS Negl Trop Dis; 2015; 9(6):e0003773. PubMed ID: 26042772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two interacting binding sites for quinacrine derivatives in the active site of trypanothione reductase: a template for drug design.
    Saravanamuthu A; Vickers TJ; Bond CS; Peterson MR; Hunter WN; Fairlamb AH
    J Biol Chem; 2004 Jul; 279(28):29493-500. PubMed ID: 15102853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metal-based compounds as prospective antileishmanial agents: inhibition of trypanothione reductase by selected gold complexes.
    Colotti G; Ilari A; Fiorillo A; Baiocco P; Cinellu MA; Maiore L; Scaletti F; Gabbiani C; Messori L
    ChemMedChem; 2013 Oct; 8(10):1634-7. PubMed ID: 24039168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 8-Methoxy-naphtho[2,3-b]thiophen-4,9-quinone, a non-competitive inhibitor of trypanothione reductase.
    Zani CL; Fairlamb AH
    Mem Inst Oswaldo Cruz; 2003 Jun; 98(4):565-8. PubMed ID: 12937775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trypanothione reductase from Trypanosoma cruzi. Catalytic properties of the enzyme and inhibition studies with trypanocidal compounds.
    Jockers-Scherübl MC; Schirmer RH; Krauth-Siegel RL
    Eur J Biochem; 1989 Mar; 180(2):267-72. PubMed ID: 2647489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptoid inhibition of trypanothione reductase as a potential antitrypanosomal and antileishmanial drug lead.
    Chan C; Yin H; McKie JH; Fairlamb AH; Douglas KT
    Amino Acids; 2002 Jun; 22(4):297-308. PubMed ID: 12107758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Privileged structure-guided synthesis of quinazoline derivatives as inhibitors of trypanothione reductase.
    Cavalli A; Lizzi F; Bongarzone S; Brun R; Luise Krauth-Siegel R; Bolognesi ML
    Bioorg Med Chem Lett; 2009 Jun; 19(11):3031-5. PubMed ID: 19414258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, inhibition potency, binding mode, and antiprotozoal activities of fluorescent inhibitors of trypanothione reductase based on mepacrine-conjugated diaryl sulfide scaffolds.
    Eberle C; Burkhard JA; Stump B; Kaiser M; Brun R; Krauth-Siegel RL; Diederich F
    ChemMedChem; 2009 Dec; 4(12):2034-44. PubMed ID: 19847846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2-Amino diphenylsulfides as inhibitors of trypanothione reductase: modification of the side chain.
    Baillet S; Buisine E; Horvath D; Maes L; Bonnet B; Sergheraert C
    Bioorg Med Chem; 1996 Jun; 4(6):891-9. PubMed ID: 8818240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structures of Trypanosoma brucei methionyl-tRNA synthetase with urea-based inhibitors provide guidance for drug design against sleeping sickness.
    Koh CY; Kim JE; Wetzel AB; de van der Schueren WJ; Shibata S; Ranade RM; Liu J; Zhang Z; Gillespie JR; Buckner FS; Verlinde CL; Fan E; Hol WG
    PLoS Negl Trop Dis; 2014 Apr; 8(4):e2775. PubMed ID: 24743796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parasite-specific trypanothione reductase as a drug target molecule.
    Krauth-Siegel RL; Inhoff O
    Parasitol Res; 2003 Jun; 90 Suppl 2():S77-85. PubMed ID: 12709793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-throughput screening affords novel and selective trypanothione reductase inhibitors with anti-trypanosomal activity.
    Martyn DC; Jones DC; Fairlamb AH; Clardy J
    Bioorg Med Chem Lett; 2007 Mar; 17(5):1280-3. PubMed ID: 17197182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel aryl β-aminocarbonyl derivatives as inhibitors of Trypanosoma cruzi trypanothione reductase: binding mode revised by docking and GRIND2-based 3D-QSAR procedures.
    de Paula da Silva CH; Bernardes LS; da Silva VB; Zani CL; Carvalho I
    J Biomol Struct Dyn; 2012; 29(6):702-16. PubMed ID: 22546000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.